Is Nymox The Next Unknown Biotech Turned High Flyer?
5d 1m 3m 1y 5y 10y
There is research on this stock available only to PRO subscribers.
There are no Transcripts on NYMX.
Nymox Reports Positive Update on Nerve Sparing and Sexual Function Preservation in Men Treated With NX-1207GlobeNewswire (Jun 17, 2014)
GlobeNewswire (Jun 11, 2014)
GlobeNewswire (May 21, 2014)
GlobeNewswire (May 15, 2014)
GlobeNewswire (May 8, 2014)
GlobeNewswire (May 6, 2014)
GlobeNewswire (Apr 30, 2014)
NYMX vs. ETF Alternatives
Nymox Pharmaceutical Corp along with its subsidiaries is a biopharmaceutical corporation, engaged in research and development of diagnostics and drugs for brain disorders and diseases of the aged with an emphasis on Alzheimer's disease.